Results 171 to 180 of about 10,858 (213)

Tenofovir alafenamide

Reactions Weekly, 2023
openaire   +1 more source

Tenofovir-alafenamide

Reactions Weekly
  +4 more sources

Entecavir/tenofovir-alafenamide

Reactions Weekly, 2023
openaire   +1 more source

Bictegravir/emtricitabine/tenofovir-alafenamide

Reactions Weekly, 2023
  +4 more sources

Tenofovir-alafenamide withdrawal

Reactions Weekly, 2022
openaire   +1 more source

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

Lancet, The, 2021
Shahin Lockman, Lynda Stranix-Chibanda, Lee Fairlie   +2 more
exaly  

Antineoplastics/tenofovir-alafenamide

Reactions Weekly, 2022
openaire   +1 more source

Fanconi Syndrome and Tenofovir Alafenamide

Annals of Internal Medicine, 2019
Hortensia, Álvarez, Josep M, Llibre
openaire   +4 more sources

Tenofovir alafenamide

Reactions Weekly, 2019
openaire   +1 more source

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Lancet, The, 2020
Kenneth Mayer, Peter L Anderson, Robert M Grant   +2 more
exaly